Want to see TECH full AI Analyst Report?
Revenue by Segment
Breaks total sales into the company’s product or business-line categories so you can see which areas drive growth and which lag. Useful for assessing diversification, dependence on key products, and where management is allocating resources to expand or defend market share.Protein Sciences is the clear revenue anchor—steady, resilient and recovering after cyclical dips—while Diagnostics & Spatial Biology is the fastest-growing diversifier, delivering consistent quarter-to-quarter expansion that should underpin long-term margin improvement. Small 'Other' contributions and large swings in intersegment eliminations look like accounting/reclassification noise (and one apparent 2026‑Q1 Protein Sciences data anomaly); don’t mistake those blips for underlying operating momentum—watch core segment trends and underlying bookings for true signal.
Date | Other | Intersegment | Protein Sciences | Diagnostics and Spatial Biology |
|---|---|---|---|---|
Jun 30, 2026 | $0.00 | -$144.00K | $231.19M | $90.14M |
Mar 31, 2026 | $0.00 | -$325.00K | $221.54M | $85.59M |
Dec 31, 2025 | $0.00 | -$387.00K | $215.08M | $81.18M |
Sep 30, 2025 | $5.44M | -$530.00K | $202.19M | $79.46M |
Jun 30, 2025 | $0.00 | $787.00K | $226.47M | $89.70M |
Mar 31, 2025 | $0.00 | -$737.00K | $227.69M | $89.23M |
Dec 31, 2024 | $1.85M | -$504.00K | $211.55M | $84.14M |
Sep 30, 2024 | $2.30M | -$572.00K | $204.53M | $83.19M |
Jun 30, 2024 | $2.06M | -$628.00K | $213.99M | $90.68M |
Mar 31, 2024 | $2.09M | -$765.00K | $214.59M | $87.51M |